DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.65) by 21.54 percent. This is a 53.21 percent increase over losses of $(1.09) per share from the
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
DarioHealth (NASDAQ:DRIO) is set to give its latest quarterly earnings report on Monday, 2022-11-14. Here's what investors need to know before the announcement.
Analysts estimate that DarioHealth will report an earnings per share (EPS) of $-0.76.
Gainers
HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million.
Dario to support City employees with integrated solutions addressing diabetes, hypertension, weight management, musculoskeletal and behavioral health in company's first government contract win
NEW YORK, Oct.